FDA to weigh easing limits on unproven peptides favored by RFK Jr. and other MAHA figures Pittsburgh Post Gazette BPC 157 Banned: Key Facts on the Latest FDA Decision The Peptide Craze Part 2: BPC 157, NAD and the Truth Behind the Longevity Molecule Hype FDA Compliance for Peptide Therapy and BPC 157 Holt Law The U.S. Food and Drug Administration is moving toward allowing compounding pharmacies to produce more than a dozen injectable peptides that were banned because of potentially significant safety risks, the New York Peptides are surging in popularity. There's little evidence that they work.